NIKKI FITCH: Open Payments
NPI 1326518192 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 53 payments from 9 companies in 2025. Trend: 2023 $729 · 2024 $859 · 2025 $1,088
Food & beverage: $1,088
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $416 |
| ABBVIE INC. | 17 | $367 |
| Novo Nordisk Inc | 4 | $75 |
| Exact Sciences Corporation | 3 | $70 |
| PFIZER INC. | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Amgen Inc. | 1 | $17 |
Products named: FARXIGA, VRAYLAR, Ozempic, Cologuard Collection Kit, AIRSUPRA, QULIPTA, NURTEC ODT, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
